(Q36550717)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

0 references

1 reference

title

Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

main subject

venous thromboembolism

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Simon McRae

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Huyen Tran

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Jeff Ginsberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Clive Kearon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

9533

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

371-378

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16876665%20AND%20SRC:MED&resulttype=core&format=json

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

The post-thrombotic syndrome: current knowledge, controversies, and directions for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Duration of anticoagulation following venous thromboembolism: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

The risk of recurrent venous thromboembolism in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

High risk of recurrent venous thromboembolism in men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Recurrent venous thromboembolism in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zürich study)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

A prospective controlled study of the efficacy of short-term anticoagulation therapy in patients with deep vein thrombosis of the lower extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Clotting activation after oral anticoagulant therapy discontinuation: a risk factor for recurrent venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969110-1

7 January 2021